New hope for tough bladder cancer: drug duo shows promise in trial

NCT ID NCT03022825

First seen Nov 01, 2025 · Last updated May 08, 2026 · Updated 21 times

Summary

This study tests a new combination treatment for people with a type of bladder cancer that has not responded to standard therapy. The treatment involves putting two drugs directly into the bladder through a catheter. The goal is to see if this approach can eliminate the cancer or keep it from coming back. About 190 adults with high-grade non-muscle invasive bladder cancer are taking part.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for BLADDER CANCER are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Locations

  • Accument Rx

    Albuquerque, New Mexico, 87109, United States

  • Adult & Pediatric Urology

    Omaha, Nebraska, 68114, United States

  • Alaska Clinical Research Center

    Anchorage, Alaska, 99503, United States

  • Arkansas Urology

    Little Rock, Arkansas, 72211, United States

  • Associated Urologists of North Carolina

    Raleigh, North Carolina, 27612, United States

  • Clinical Research Center of Florida

    Pompano Beach, Florida, 33060, United States

  • Dwight D. Eisenhower Army Medical Center

    Augusta, Georgia, 30905, United States

  • Hoag Memorial Hospital

    Newport Beach, California, 92663, United States

  • Integrated Medical Professionals

    New York, New York, 10016, United States

  • Karmanos Cancer Institute

    Detroit, Michigan, 48201, United States

  • Madigan Army Medical Center

    Tacoma, Washington, 98431, United States

  • Moffitt Cancer Center

    Tampa, Florida, 33612, United States

  • Premier Medical Group of the Hudson Valley

    Poughkeepsie, New York, 12601, United States

  • Roswell Park Cancer Insitute

    Buffalo, New York, 14263, United States

  • Skyline Urology

    Sherman Oaks, California, 91411, United States

  • Skyline Urology

    Torrance, California, 90505, United States

  • Thomas Jefferson University

    Philadelphia, Pennsylvania, 19107, United States

  • UCLA Department of Urology

    Los Angeles, California, 90024, United States

  • UNC Chapel Hill

    Chapel Hill, North Carolina, 27599, United States

  • University of Chicago Medical Center

    Chicago, Illinois, 60637, United States

  • University of Hawaii Cancer Center

    Honolulu, Hawaii, 96814, United States

  • University of Miami Miller School of Medicine-Sylvester Comprehensive Cancer Center

    Miami, Florida, 33136, United States

  • University of Michigan

    Ann Arbor, Michigan, 48109, United States

  • University of Rochester

    Rochester, New York, 14642, United States

  • Urology Associates, PC

    Englewood, Colorado, 80113, United States

  • Vanderbilt University Medical Center

    Nashville, Tennessee, 37232, United States

  • Virginia Urology

    Richmond, Virginia, 23235, United States

  • Winthrop University Hospital Department of Urology

    Garden City, New York, 11530, United States

Conditions

Explore the condition pages connected to this study.